Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.99 | N/A |
| PEG Ratio (TTM) | 0.27 | N/A |
| P/S Ratio (TTM) | 24.08 | N/A |
| P/B Ratio (TTM) | 1.07 | N/A |
| P/FCF Ratio (TTM) | 146.10 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.82 | N/A |
| Price to 5YR AVG FCF Ratio | 13.50 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.07% | N/A |
| ROE (TTM) | 3.93% | N/A |
| Net Profit Margin (TTM) | 92.95% | N/A |
| ROIC 5YR AVG | 5.44% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | 52.11% | 22.17% |
| Revenue | N/A | 60.75% | 26.53% |
| Net Income | N/A | 51.26% | 20.64% |
| Cash Flow | N/A | 592.80% | 435.44% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.42 | N/A |
| Quick Ratio (TTM) | 0.42 | N/A |
| D/E Ratio (TTM) | 0.26 | N/A |
| Interest Coverage (TTM) | 2.58 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 3.35 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.53% | N/A |